Outcomes of Left Main Revascularization in Patients with Anemia: Gulf Left Main Registry
Amin Daoulah,Maryam Jameel Naser,Ahmad Hersi,Nooraldaem Yousif,Abdulaziz Alasmari,Wael Almahmeed,Hazza A AlZahrani,Alwaleed Aljohar,Mohammed Alshehri,Badr Alzahrani,Duna Basudan,Hind Alosaimi,Reda Abuelatta,Turki Al Garni,Mohamed Ajaz Ghani,Haitham Amin,Husam A Noor,Shahrukh Hashmani,Faisal Omar M Al Nasser,Hameedullah M Kazim,Wael Refaat Wael Refaat,Ehab Selim,Ahmed Jamjoom,Osama El-Sayed,Taher Hassan,Ziad Dahdouh,Jairam Aithal,Ahmed Diab,Ahmed M Ibrahim,Abdelmaksoud Elganady,Mohammed A Qutub,Mohamed N Alama,Abdulwali Abohasan,Wael Tawfik,Mohammed Balghith,Seraj Abualnaja,Adnan Fathey Hussien,Ibrahim A M Abdulhabeeb,Osama Ahmad,Mohamed Ramadan,Abdulrahman H Alqahtani,Faisal Al Samadi,Wael Qenawi,Ahmed Shawky,Ahmed A Ghonim,Amr A Arafat,Ahmed Elmahrouk,Youssef Elmahrouk,Niranjan Hiremath,Abeer M Shawky,Farhan M Asrar,Tarek Farghali,Issam Altnji,Khalid Aljohani,Mohammed Alotaiby,Abdulrahman M Alqahtani,Amir Lotfi
DOI: https://doi.org/10.1159/000530305
IF: 1.9
Cardiology
Abstract:Introduction: The aim of this study was to evaluate the effects of baseline anemia and anemia following revascularization on outcomes in patients with unprotected left main coronary artery (ULMCA) disease. Methods: This was a retrospective, multicenter, observational study conducted between January 2015 and December 2019. The data on patients with ULMCA who underwent revascularization through percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) were stratified by the hemoglobin level at baseline into anemic and non-anemic groups to compare in-hospital events. The pre-discharge hemoglobin following revascularization was categorized into very low (<80 g/L for men and women), low (≥80 and ≤119 g/L for women and ≤129 g/L for men), and normal (≥130 g/L for men and ≥120 g/L for women) to assess impact on follow-up outcomes. Results: A total of 2,138 patients were included, 796 (37.2%) of whom had anemia at baseline. A total of 319 developed anemia after revascularization and moved from being non-anemic at baseline to anemic at discharge. There was no difference in hospital major adverse cardiac and cerebrovascular event (MACCE) and mortality between CABG and PCI in anemic patients. At a median follow-up time of 20 months (interquartile range [IQR]: 27), patients with pre-discharge anemia who underwent PCI had a higher incidence of congestive heart failure (CHF) (p < 0.0001), and those who underwent CABG had significantly higher follow-up mortality (HR: 9.85 (95% CI: 2.53-38.43), p = 0.001). Conclusion: In this Gulf LM study, baseline anemia had no impact upon in-hospital MACCE and total mortality following revascularization (PCI or CABG). However, pre-discharge anemia is associated with worse outcomes after ULMCA disease revascularization, with significantly higher all-cause mortality in patients who had CABG, and a higher incidence of CHF in PCI patients, at a median follow-up time of 20 months (IQR: 27).